AU2004261591A1 - Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands - Google Patents

Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands Download PDF

Info

Publication number
AU2004261591A1
AU2004261591A1 AU2004261591A AU2004261591A AU2004261591A1 AU 2004261591 A1 AU2004261591 A1 AU 2004261591A1 AU 2004261591 A AU2004261591 A AU 2004261591A AU 2004261591 A AU2004261591 A AU 2004261591A AU 2004261591 A1 AU2004261591 A1 AU 2004261591A1
Authority
AU
Australia
Prior art keywords
imidazol
triazolo
ylmethyl
propyl
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004261591A
Other languages
English (en)
Inventor
Bertrand L. Chenard
Yang Gao
Bingsong Han
George Maynard
Kenneth Shaw
Linghong Xie
Yuelian Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurogen Corp
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of AU2004261591A1 publication Critical patent/AU2004261591A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2004261591A 2003-07-25 2004-07-23 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands Abandoned AU2004261591A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US49000603P 2003-07-25 2003-07-25
US60/490,006 2003-07-25
US54308304P 2004-02-09 2004-02-09
US60/543,083 2004-02-09
PCT/US2004/023794 WO2005012306A2 (en) 2003-07-25 2004-07-23 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands

Publications (1)

Publication Number Publication Date
AU2004261591A1 true AU2004261591A1 (en) 2005-02-10

Family

ID=34118813

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004261591A Abandoned AU2004261591A1 (en) 2003-07-25 2004-07-23 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands

Country Status (20)

Country Link
US (2) US7271170B2 (cg-RX-API-DMAC7.html)
EP (1) EP1648899B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007500130A (cg-RX-API-DMAC7.html)
KR (1) KR20060098425A (cg-RX-API-DMAC7.html)
AR (1) AR045117A1 (cg-RX-API-DMAC7.html)
AT (1) ATE350382T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004261591A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0412908A (cg-RX-API-DMAC7.html)
CA (1) CA2537331A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107565T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004004143T2 (cg-RX-API-DMAC7.html)
DK (1) DK1648899T3 (cg-RX-API-DMAC7.html)
ES (1) ES2278345T3 (cg-RX-API-DMAC7.html)
IL (1) IL173265A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06000887A (cg-RX-API-DMAC7.html)
NZ (1) NZ544262A (cg-RX-API-DMAC7.html)
PL (1) PL1648899T3 (cg-RX-API-DMAC7.html)
PT (1) PT1648899E (cg-RX-API-DMAC7.html)
TW (1) TW200524937A (cg-RX-API-DMAC7.html)
WO (1) WO2005012306A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482366B2 (en) * 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
EP1619948A4 (en) * 2003-05-05 2007-02-14 Neurogen Corp SUBSTITUTED IMIDAZOLOPYRAZINE AND TRIAZOLOPYRAZINE DERIVATIVES: GABAA RECEPTOR LIGANDS
WO2006093911A2 (en) * 2005-03-02 2006-09-08 Neurogen Corporation Thiazolylmethyl and oxazolylmethyl heteroaryl derivatives
EP1928237A4 (en) 2005-09-02 2011-03-09 Abbott Lab NEW HETEROCYCLES BASED ON IMIDAZO
JP2010523716A (ja) * 2007-04-11 2010-07-15 サイプレス バイオサイエンシズ，インク． ベンゾジアゼピン受容体拮抗薬を用いるダウン症候群の治療
US8546394B2 (en) 2007-04-17 2013-10-01 Bristol-Myers Squibb Company Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
US20090270373A1 (en) * 2008-04-11 2009-10-29 Cypress Biosciences, Inc. Treatment of down syndrom with benzodiazepine receptor antagonists

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544057A (en) * 1895-08-06 Bill and letter file
DE60014339T8 (de) * 1999-04-02 2006-04-27 Neurogen Corp., Branford Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren
US6737242B1 (en) 1999-05-07 2004-05-18 Neurogen Corporation Methods for screening GABA-modulatory compounds for specified pharmacological activities
GB9929687D0 (en) 1999-12-15 2000-02-09 Merck Sharp & Dohme Therapeutic agents
US6552037B2 (en) 2000-06-30 2003-04-22 Neurogen Corporation 2-Substituted imidazo[1,2-A]pyridine derivatives
GB0027561D0 (en) * 2000-11-10 2000-12-27 Merck Sharp & Dohme Therapeutic agents
US6900215B2 (en) * 2000-12-15 2005-05-31 Merck Sharp & Dohme Ltd. Imidazo-pyrimidine derivatives as ligands for gaba receptors
PA8535601A1 (es) * 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa
TWI248936B (en) * 2001-03-21 2006-02-11 Merck Sharp & Dohme Imidazo-pyrimidine derivatives as ligands for GABA receptors
US7030128B2 (en) 2001-03-23 2006-04-18 Merck Sharp & Dohme Ltd. Imidazo-pyrimidine derivatives as ligands for GABA receptors
IL159811A0 (en) 2001-07-13 2004-06-20 Neurogen Corp Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
GB0128499D0 (en) * 2001-11-28 2002-01-23 Merck Sharp & Dohme Therapeutic agents
US7030144B2 (en) 2002-05-02 2006-04-18 Neurogen Corporation Substituted imidazole derivatives: GABAA receptor ligands
CA2484936A1 (en) 2002-05-08 2004-05-21 Neurogen Corporation Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands
JP2006502974A (ja) 2002-05-17 2006-01-26 ニューロジェン コーポレイション 置換環縮合イミダゾール誘導体：ｇａｂａａ受容体リガンド
CN100579579C (zh) 2002-10-01 2010-01-13 诺华疫苗和诊断公司 抗癌及抗感染性疾病组合物及其使用方法
DE60307499T2 (de) 2002-11-08 2007-02-01 Neurogen Corp., Branford 4-imidazol-1-ylmethylpyrimidinderivate als liganden für gabaa-rezeptoren
EP1619948A4 (en) 2003-05-05 2007-02-14 Neurogen Corp SUBSTITUTED IMIDAZOLOPYRAZINE AND TRIAZOLOPYRAZINE DERIVATIVES: GABAA RECEPTOR LIGANDS

Also Published As

Publication number Publication date
US20050038043A1 (en) 2005-02-17
KR20060098425A (ko) 2006-09-18
NZ544262A (en) 2009-06-26
US7271170B2 (en) 2007-09-18
DE602004004143T2 (de) 2007-10-11
BRPI0412908A (pt) 2006-09-26
WO2005012306A3 (en) 2005-04-14
MXPA06000887A (es) 2006-04-19
PL1648899T3 (pl) 2007-06-29
TW200524937A (en) 2005-08-01
HK1089446A1 (en) 2006-12-01
EP1648899B1 (en) 2007-01-03
DK1648899T3 (da) 2007-04-02
US20080139580A1 (en) 2008-06-12
ES2278345T3 (es) 2007-08-01
DE602004004143D1 (de) 2007-02-15
WO2005012306A2 (en) 2005-02-10
JP2007500130A (ja) 2007-01-11
ATE350382T1 (de) 2007-01-15
IL173265A0 (en) 2006-06-11
CA2537331A1 (en) 2005-02-10
PT1648899E (pt) 2007-03-30
CY1107565T1 (el) 2013-03-13
AR045117A1 (es) 2005-10-19
EP1648899A2 (en) 2006-04-26

Similar Documents

Publication Publication Date Title
KR102025487B1 (ko) Ｐｄｅ１０ａ 효소 저해제로서의 신규한 페닐이미다졸 유도체
US6936617B2 (en) Heteroaryl substituted fused bicyclic heteroaryl compound as GABAA receptor ligands
KR101261514B1 (ko) 피롤로피라진 키나아제 저해제
US20040110778A1 (en) Heterocyclic compounds as ligands of the GABAA receptor
AU2004270713A1 (en) Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands
WO2006052546A2 (en) Pyrazolylmethyl heteroaryl derivatives
AU2009218609A1 (en) Pyrrolopyrazine kinase inhibitors
US20060247245A1 (en) Substituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands
KR20120123276A (ko) Ｐｄｅ10ａ 효소 저해제로서의 2-아릴이미다졸 유도체
KR20140009192A (ko) Ｐｄｅ１０ａ 효소 저해제로서 이미다졸 유도체
US20090023737A1 (en) Imidazo-Pyridazines, Triazolo-Pyridazines and Related Benzodiazepine Receptor Ligands
US20080139580A1 (en) Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
EP4067358A1 (en) (s)-1-(5-((pyridin-3-yl)thio)pyrazin-2-yl)-4'h,6'h-spiro[piperidine-4,5'-pyrrolo[1,2-b]pyrazol]-4'-amine derivatives and similar compounds as shp2 inhibitors for the treatment of e.g. cancer
AU2014261070A1 (en) Imidazo-triazine derivatives as PDE10 inhibitors
US7122546B2 (en) Imidazol-1-ylmethyl pyridazine derivatives
US20080132510A1 (en) Imidazolylmethyl and Pyrazolylmethyl Heteroaryl Derivatives
EP2964627B1 (en) Inhibitors of bruton's tyrosine kinase
CN100457756C (zh) 咪唑-嘧啶类及三唑-嘧啶类:苯并二氮平受体配体
EP1880998A1 (en) Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
HK1089446B (en) Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
KR20250084154A (ko) Shp2 억제제로서의 아졸 유도체
US20080167324A1 (en) Thiazolymethyl and Oxazolylmethyl Heteroaryl Derivatives
HK1178534A (en) Pyrrolopyrazine derivatives and their use as jak and syk inhibitors

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application